National Resilience
San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA
Compare mRNA/LNP CDMOs in USA
Compare Gene Therapy CDMOs in USA
Compare Cell Therapy CDMOs in USA
Compare Lentiviral CDMOs in USA
9 confirmed programs
· 8 sponsors
· Last scored 2026-11-02
73.7
Signal Score
✓ FDA Inspections (1)
✓ Clinical Trials (9)
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
✓ HC GMP (2)
Quick Facts: National Resilience
- Signal Score
- 73.7/100 (as of 2026-11-02)
- Quality Compliance
- 95.7/100
- Headquarters
- San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA
- Modalities
- mRNA, Gene Therapy, Cell Therapy, Lentiviral
- Active Programs
- 9 confirmed from ClinicalTrials.gov across 8 sponsors
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About National Resilience
$800M+ raised.
Signal Score & Pillar Breakdown
Quality Compliance
95.7
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2025-01-21)
Most Recent HC OutcomeCompliant · 2024-12-16
HC Attribution2 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Operations
58.3
9 active programs across 8 sponsors
Modalities: Lentiviral, Cell Therapy, mRNA, Gene Therapy
3 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov
9 active programs across 8 sponsors · Modalities: Lentiviral, Cell Therapy, mRNA, Gene Therapy · 3 programs in advanced phases (Phase 2/3)
Programs
9
Sponsors8
ModalitiesmRNA, Gene Therapy, Cell Therapy, Lentiviral
9 active programs across 8 sponsors
Modalities: Lentiviral, Cell Therapy, mRNA, Gene Therapy
3 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov facility matching
Source: ClinicalTrials.gov · Retrieved Nov 21, 2026
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
68.0
3 manufacturing sites
Broad modality coverage (4 modalities)
Sites: Research Triangle Park, NC, Boston, MA, San Diego, CA
Source: company profiles (manufacturing sites, modality breadth)
3 manufacturing sites
StatusAvailable
3 manufacturing sites
Broad modality coverage (4 modalities)
Sites: Research Triangle Park, NC, Boston, MA, San Diego, CA
3 manufacturing sites
Broad modality coverage (4 modalities)
National Resilience FDA Inspection History
2025-01
NAI
VAI
OAI
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2025-01-21 |
Resilience US, Inc.
West Chester, Ohio
Facility-linked
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Nov 21, 2026
National Resilience FDA 483 Findings 6 observations · 2025-01-21 → 2025-01-21 ?
By subsystem
By severity
- 3 — Moderate: 3
- 2 — Minor: 3
- Repeat observations: 0
Most severe findings
-
Complete test data included in records
"Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards."
-
Identification of Person Performing Review of Lab Records
"Laboratory records are deficient in that they do not include the initials and signature of the second person reviewing the record for accuracy."
-
Investigations of discrepancies, failures
"There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed."
Clinical Activity 9 studies
NCT07190755
Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients...
NA
Recruiting
NCT06364631
CARE1 Pragmatic Clinical Trial
PHASE3
Recruiting
NCT06072612
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced...
PHASE3
Recruiting
NCT05835895
Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee...
PHASE1
Active Not Recruiting
NCT05298293
Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma
NA
Not Yet Recruiting
NCT04023071
FT516 in Subjects With Advanced Hematologic Malignancies
PHASE1
Terminated
NCT04093622
Long-term Follow-Up Study Following Treatment With Fate Therapeutics'...
NA
Terminated
NCT00073463
Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the...
PHASE2/PHASE3
Terminated
NCT03601442
CTL019 Out of Specification MAP for ALL or DLBCL Patients
NA
Available
Source: ClinicalTrials.gov · Retrieved Nov 21, 2026
Hiring Activity 100+ open roles Beta
From public job postings on National Resilience's careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
100+
open roles (the board lists only its ~100 newest)
94
in manufacturing, quality, PD/MSAT, engineering or regulatory (94%)
Trend from Nov 25, 2026
Tracking started Oct 26, 2026. 30-day change shows after 30 days, 90-day after Jan 24, 2027.
Since Nov 19, 2026: 4 new postings, 4 taken down.
What this may mean
- 6 of the 10 openings at Mississauga, ON, CAN (Meadowpine Blvd) are in quality (QA/QC). That fits added testing or batch-release work, but it can also be normal turnover.
By function
By site
West Chester, OH, USA
profile site
32 mfg/ops · 8 QA/QC · 5 PD/MSAT · 23 eng. · 5 other 73
32 mfg/ops · 8 QA/QC · 5 PD/MSAT · 23 eng. · 5 other 73
Blue Ash, OH, USA
5 mfg/ops · 3 QA/QC · 2 PD/MSAT · 6 eng. 16
5 mfg/ops · 3 QA/QC · 2 PD/MSAT · 6 eng. 16
Mississauga, ON, CAN (Meadowpine Blvd)
· 6 QA/QC · 4 eng. 10
· 6 QA/QC · 4 eng. 10
Remote, MA, USA
· 1 other 1
· 1 other 1
Latest postings
Manufacturing Technician III, Mechanic, Device Assembly, Days
Manufacturing & operations · West Chester, OH, USA
Manufacturing Technician II, Sterile Filling
Manufacturing & operations · West Chester, OH, USA
Facilities Maintenance Technician III, Nights
Engineering & facilities · Blue Ash, OH, USA
Validation Engineer III, MSAT
Process development & MSAT · West Chester, OH, USA
Supervisor, Manufacturing, Inspection, Nights
Manufacturing & operations · West Chester, OH, USA
Manufacturing Technician IV, Sterile Filling
Manufacturing & operations · West Chester, OH, USA
Manufacturing Technician IV, Lead, DAP, Nights
Manufacturing & operations · West Chester, OH, USA
Manufacturing Technician II, Formulation
Process development & MSAT · West Chester, OH, USA
Maintenance Technician II, Days
Engineering & facilities · West Chester, OH, USA
Cyber Security Engineer II
Other (finance, HR, IT, other) · Remote, MA, USA
Engineering Technician
Engineering & facilities · West Chester, OH, USA
Associate II, Quality Assurance, Day Shift
Quality (QA / QC) · West Chester, OH, USA
Coverage: counted from National Resilience's own careers board.
The board publishes only its ~100 newest postings, so the real number of open roles is likely higher.
Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source:
resilience.wd1.myworkdayjobs.com
· Checked Nov 20, 2026 · Tracking since Oct 26, 2026
Frequently Asked Questions About National Resilience
How many FDA inspections does National Resilience have on record?
CDMO Signal tracks 1 FDA inspection for National Resilience, sourced from the FDA inspection database. See the full inspection history above.
Has National Resilience received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for National Resilience.
How many clinical programs is National Resilience linked to?
National Resilience is associated with 9 clinical trials in CDMO Signal's ClinicalTrials.gov-sourced data.
What is National Resilience's CDMO Signal Score?
National Resilience has a Signal Score of 74/100, based on quality, operations, financial stability, and capacity data.
Evaluating National Resilience for a manufacturing program?
Use the free AI matchmaker to compare National Resilience against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Lonza
Basel, Switzerland
Signal Score: 72.8
AAV, Lentiviral, Cell Therapy, mRNA, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation, Small Molecule API, High-Potency APIs, Oral Solid Dose
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 82.9
AAV, Lentiviral, Plasmid, mRNA
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.9
mRNA, Biologics, Cell Therapy
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 79.9
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation
Compare National Resilience with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.